Drugs based on mechanisms of action that directly stimulate uptake of glucose by skeletal muscle tissues, independent of endogenous and exogenous insulin, are thus needed for individuals who have developed insulin resistance or are experiencing undesired side effects with current treatments. Here, INS is linked to Insulin resistance.